ERBB2 and breast neoplasm: We found that, in agreement with its proposed role as tumor suppressor [20], deletion of β2-chimaerin in MMTV-Neu mice increases their susceptibility to develop breast tumors, as tumor latency was significantly reduced and mice had a higher incidence of preneoplasic lesions in the mammary glands.